Biomarin Pharmaceutical Inc (NASDAQ: BMRN) shares are falling in reaction to positive data from BridgeBio Pharma Inc's (NASDAQ: BBIO) dwarfism drug, heating the competition.
Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.21 by 9.52 percent. This is a 35.29 percent increase over earnings of $0.17 per share from
Caesars Entertainment, Inc. and Nobu Hospitality – the global lifestyle brand founded by Nobu Matsuhisa, Robert De Niro and Meir Teper – today announced the expansion of